A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review

Author:

Pushkaran AnjaliORCID,Chattu Vijay KumarORCID,Narayanan Prakash

Abstract

IntroductionThe COVAX alliance is a novel approach to international partnership in global health intended to achieve the worthy goal of ‘COVID-19 vaccine equity’. This study aimed to identify the implementation challenges and framework gaps of COVAX and to explore the interconnected global health policy and governance gaps in ensuring equity, accessibility and affordability of vaccines.MethodsA scoping review was conducted to identify the implementation challenges and framework gaps of COVAX and related global health policy and governance gaps. A search was carried out in PubMed, Scopus, Springer Link and Embase databases. Manually searched the grey literature, such as official reports and articles. EndNote V.20 was used to manage the evidence screening, and data extraction was carried out in Microsoft Excel.ResultsSearches of four electronic databases and official UN, GAVI and WHO websites identified 4686 pieces of evidence. The 937 duplicates were removed, and the remaining 3749 articles were screened for the title and abstract. Most articles were eliminated as they do not address global COVAX or COVID-19 vaccine equity. The remaining 53 pieces of evidence were reviewed for full text, and ultimately 40 articles found eligible were included in the scoping review.ConclusionsThe implementation challenges of COVAX were attributed mainly to the phenomenon of vaccine nationalism by rich countries. The future global health policy and governance structure must be re-examined to address the inadequacies of such novel super public-and-private partnership models.

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference65 articles.

1. COVAX explained. Available: https://www.gavi.org/vaccineswork/covax-explained?gclid=Cj0KCQiAyMKbBhD1ARIsANs7rEGx4i5TYeVbcRoaSOh_T7IlJ9t_d-IdpmbeYhag_RuMc83FT4locZIaAmQeEALw_wcB [Accessed 19 Nov 2022].

2. Storeng KT , de Bengy Puyvallée A , Stein F . “COVAX and the rise of the “super public-private partnership” for global health”. Glob Public Health 2021:1–17. doi:10.1080/17441692.2021.1987502

3. COVAX Joint Statement: call to action to equip COVAX to deliver 2 billion doses in 2021, Available: https://www.who.int/news/item/27-05-2021-covax-joint-statement-call-to-action-to-equip-covax-to-deliver-2-billion-doses-in-2021

4. Ghana becomes recipient of historic first shipment of COVAX vaccine, Available: https://www.unicef.org/press-releases/ghana-becomes-recipient-historic-first-shipment-covax-vaccine [Accessed 24 Dec 2022].

5. COVAX global supply forecast, Available: https://www.who.int/publications/m/item/covax-global-supply-forecast [Accessed 19 Nov 2022].

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3